• Precision Medicine AI Agent Platform
          • Precision Medicine AI Agent Platform
          • Security & Compliance
        • Solutions
          • Overview
          • Agent Intelligence (AI)
          • Sample Intelligence (SI)
          • Biomarker Intelligence (BI)
        • Resources
          • News & Insights
          • Webinars & Events
          • FAQs
          • Case Studies
          • Literature
        • About Us
          • Overview
          • Leadership
          • Careers
          • Contact Us
  • Search
  • Menu Menu
Precision Medicine AI Agent Platform Solutions
Log in Book A Demo
QuartzBio Team

About QuartzBio Team

This author has not written his bio yet.
But we are proud to say that QuartzBio Team contributed 32 entries already.

Entries by QuartzBio Team

Key Takeaways: Biomarker Intelligence Summit, March 2024 

Last week, biomarker intelligence leaders from Boston-area R&D organizations got a firsthand look at the powerful predictive and prescriptive intelligence that will soon infuse QuartzBio’s AI Biomarker Intelligence Platform, after sharing common challenges facing data-rich precision medicine clinical programs.

Tell me what I don’t know: AI-enhanced decisions in biomarker-informed trials

Tobi Guennel, PhD, QuartzBio’s Senior Vice President of Product & Chief Architect, energized the Biomarkers & Precision Medicine track at SCOPE 2024 by showing how generative AI can address challenges faced biospecimen and biomarker operations teams, as well as clinical and translational teams, when gathering insights on samples across all parts of a complex biomarker data ecosystem.

Webinar On Demand: Taming clinical sample chaos with conversational AI

Learn how conversational AI enables you to talk to your biospecimen data. Join Bill Hall for a demo of our virtual Sample Inventory Management solution, powered by an AI-enabled Biomarker Intelligence Platform and intuitive Virtual Assistant.

Meet a QuartzBio Employee: Katie Berola 

QuartzBio’s team has deep experience in technology-enabled solutions for the life science industry. In this blog series, we invited you to get to know a member of the QuartzBio team. This month, we are delighted to talk with Katie Berola, Director of virtual Sample Inventory Management.

Spotlight on Specimens: Innovations in Biospecimen Management May Transform Precision Medicine 

In a recent article titled, “The Criticality of Specimen Management to Precision Medicine,” Brenda Yanak warned drug developers against minimizing the importance of biospecimens, so often overlooked during biomarker development.

Webinar On Demand: Unifying Clinical & Biomarker Data

Join Bill Hall for a webinar demo of the QuartzBio® enterprise Biomarker Data Management solution. We’ll show you how to generate patient profiles to view tumor burden over course of treatment, explore multi-marker views of patient profiles, and cross-reference biomarker measures across file types.

Webinar On Demand: Digitizing Biomarker Operations​–Tools to Track & Report Sample, Consent, Vendor, & Site KPIs Across Programs​

Join our webinar to learn how our clients, representing major biopharmas and biotechnology companies, have eliminated tedious data management processes and costly delays with the QuartzBio® virtual Sample Inventory Management SaaS solution.​

QuartzBio, a Part of Precision for Medicine, Acquires SolveBio and Expands Software-as-a-Service (SaaS) Data Management Solutions for Clinical Research & Development

Precision for Medicine, the first global, precision medicine, clinical research services organization today announced the strategic acquisition of SolveBio, which will now fall under the QuartzBio, part of Precision for Medicine brand and product portfolio.  

Connecting Raw, Processed, and Ancillary Data with a Biomarker Data Management Solution

Translational and clinical teams spend more than 70% of their time managing, cleaning, and harmonizing data generated in biomarker-rich clinical programs. In a recent webinar, Adam Brown demonstrated how the QuartzBio® enterprise Biomarker Data Management (eBDM) solution addresses one set of frequently intractable challenges: connecting raw, processed, and ancillary data across multiple clinical studies.

4 Strategic Imperatives for Clinical and Biomarker Operations 

Keeping track of clinical trial samples across multiple sites and vendors can be manual and tedious — we have demonstrated how Sample Intelligence can streamline the day-to-day reporting of sample collections, shipments, and discrepancies.

Page 2 of 41234

Search

QuartzBio Logo_The Precision Medicine Intelligence Company _white
  • Precision Medicine AI Agent Platform
  • Solutions
  • Log In
  • Book a Demo
  • Resources
  • About Us

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.

QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.

© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR

Web Design and Development by RainCastle Communications.

  • Precision Medicine AI Agent Platform
    • Precision Medicine AI Agent Platform
    • Security & Compliance
    • Back
  • Solutions
    • Overview
    • Agent Intelligence (AI)
    • Sample Intelligence (SI)
    • Biomarker Intelligence (BI)
    • Back
  • Resources
    • News & Insights
    • Webinars & Events
    • FAQs
    • Case Studies
    • Product Literature
    • Back
  • About Us
    • Overview
    • Leadership
    • Careers
    • Contact Us
    • Back
  • Login
  • Book a Demo

Contact App Support



Request Documentation